carbostyril has been researched along with Biliary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clausen, E; Dezube, R; Grant, JJ; Hong, G; Safirstein, J; Savant, D | 1 |
| Kunii, O; Ono, Y | 1 |
2 other study(ies) available for carbostyril and Biliary Tract Diseases
| Article | Year |
|---|---|
Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis.
Topics: Adult; Aminophenols; Benzodioxoles; Biliary Tract Diseases; Chloride Channel Agonists; Cholecystectomy; Cystic Fibrosis; Drug Combinations; Female; Humans; Indoles; Male; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2021 |
[Studies of lomefloxacin in biliary tract infections].
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bacteria; Bacterial Infections; Biliary Tract Diseases; Drug Evaluation; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones | 1989 |